Related Experiment Video
Updated: Sep 28, 2026

Purification of Pathogen Vacuoles from Legionella-infected Phagocytes
Published on: June 19, 2012
Legionella pneumophila pneumonia successfully treated with intravenous ciprofloxacin
Shusaku Haranaga1, Masato Toyama, Noriko Arakaki
1First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Nakagami-gun, Okinawa.
Abstract:
A 69-year-old man developed a cough and fever during treatment with corticosteroid (p.o. and external use) for erythroderma. Chest X-ray films revealed a consolidation shadow in the right upper lung field. Initial treatment with sulbactam sodium/ampicillin followed by imipenem/cilastatin was not effective. A urinary antigen test for Legionella was positive, making for a diagnosis of Legionella pneumonia. Intravenous treatment with ciprofloxacin (CPFX) was remarkably effective. His symptoms, chest X-ray and laboratory data rapidly improved after its initiation. Our findings strongly suggest that intravenous treatment with fluoroquinolones including CPFX should also be a first choice for Legionella pneumonia in Japan.
Insights
Legionella pneumonia can occur during corticosteroid treatment. Intravenous ciprofloxacin proved highly effective, suggesting fluoroquinolones as a first-choice treatment for this infection in Japan.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Corticosteroid therapy can predispose patients to opportunistic infections.
- Legionella pneumonia is a severe bacterial lung infection requiring effective antimicrobial treatment.
Observation:
- A 69-year-old man on corticosteroids for erythroderma developed pneumonia with cough and fever.
- Initial broad-spectrum antibiotics were ineffective; Legionella pneumonia was diagnosed via urinary antigen testing.
Findings:
- Intravenous ciprofloxacin (CPFX) demonstrated rapid and remarkable efficacy in treating Legionella pneumonia.
- Clinical symptoms, chest X-ray findings, and laboratory markers significantly improved following CPFX initiation.
Implications:
- Intravenous fluoroquinolones, including ciprofloxacin, should be considered a primary treatment option for Legionella pneumonia in Japan.
- This case highlights the importance of considering atypical infections in immunocompromised patients.
- Prompt diagnosis and targeted therapy are crucial for favorable outcomes in Legionella pneumonia.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Inhibitors of Bacterial DNA Synthesis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Cryptococcal Meningitis
Atypical Pneumonia
Urinary Tract Infection IV: Nursing Management